Digital x-ray developer Bioptics has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its CoreVision specimen radiography system.
CoreVision is designed for use in stereotactic core biopsy procedures and can send images to a PACS network via its DICOM interface, according to the Tucson, AZ-based firm.
Related Reading
Road to RSNA, Women's Imaging, Bioptics, October 26, 2007
Bioptics lands Ireland sale, June 28, 2007
Road to RSNA, Women's Imaging, Bioptics, November 9, 2006
Bioptics receives NCI grant, October 20, 2006
Copyright © 2009 AuntMinnie.com